Growth Metrics

OmniAb (OABI) Cash from Investing Activities (2021 - 2026)

OmniAb (OABI) reported Cash from Investing Activities of $8.4 million for Q1 2026, up 1060.82% year-over-year from $726727.6 in Q1 2025, and up 211.18% on a QoQ basis from $2.7 million in Q4 2025.

OmniAb (OABI) has 6 years of Cash from Investing Activities data on file, last reported at $8.4 million in Q1 2026.

  • Quarterly Cash from Investing Activities rose 1060.82% year-over-year to $8.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.8 million (down 7.55% YoY) and the FY2025 annual result came in at $6.5 million, down 82.93% from the prior year.
  • Cash from Investing Activities advanced to $8.4 million in Q1 2026 per OABI's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $19.9 million in Q1 2024 and bottomed at -$60.2 million in Q4 2022.
  • The 5-year median for Cash from Investing Activities is $2.7 million (2025), against an average of -$2.3 million.
  • The widest annual swing landed in 2023, when Cash from Investing Activities sank 841.78%; it then jumped 1060.82% in 2026.
  • Tracing OABI's Cash from Investing Activities over 5 years: stood at -$60.2 million in 2022, then jumped by 107.86% to $4.7 million in 2023, then sank by 91.86% to $385000.0 in 2024, then jumped by 604.16% to $2.7 million in 2025, then jumped by 211.18% to $8.4 million in 2026.
  • Per Business Quant, the three latest OABI Cash from Investing Activities figures stand at $8.4 million (Q1 2026), $2.7 million (Q4 2025), and -$7.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.89 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 638.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -431.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -428.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -25.54 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 8.44 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8.44 Mn
Mar 31, 2026 8.44 Mn
Dec 31, 2025 2.71 Mn
Dec 31, 2025 2.71 Mn
Sep 30, 2025 -7.67 Mn
Sep 30, 2025 -7.67 Mn
Jun 30, 2025 12.30 Mn
Jun 30, 2025 12.30 Mn
Mar 31, 2025 -878,000.00
Mar 31, 2025 -878,000.00
Dec 31, 2024 385,000.00
Dec 31, 2024 385,000.00
Sep 30, 2024 4.45 Mn
Sep 30, 2024 4.45 Mn
Jun 30, 2024 13.11 Mn
Jun 30, 2024 13.11 Mn
Mar 31, 2024 19.94 Mn
Mar 31, 2024 19.94 Mn
Dec 31, 2023 4.73 Mn
Dec 31, 2023 4.73 Mn
Sep 30, 2023 6.29 Mn
Sep 30, 2023 6.29 Mn
Jun 30, 2023 7.78 Mn
Jun 30, 2023 7.78 Mn
Mar 31, 2023 -37.17 Mn
Mar 31, 2023 -37.17 Mn
Dec 31, 2022 -60.20 Mn
Dec 31, 2022 -60.20 Mn
Sep 30, 2022 -4.88 Mn
Sep 30, 2022 -4.88 Mn
Jun 30, 2022 -4.29 Mn
Jun 30, 2022 -4.29 Mn
Mar 31, 2022 -3.95 Mn
Mar 31, 2022 -3.95 Mn
Dec 31, 2021 231.73 Mn
Dec 31, 2021 231.73 Mn